Navigation Links
Chinese women join global breast cancer trial
Date:7/30/2009

Breast cancer patients have for the first time been recruited from China to take part in an international trial of breast radiotherapy.

Researchers will evaluate how effective the treatment is for women who have had a mastectomy.

Radiotherapy works by destroying cancer cells in the treated area. The trial will investigate whether the treatment lessens the risk of the cancer returning in patients who have had a breast removed.

The results of the trial will be highly relevant in China, where breast cancer is becoming a major health care issue, particularly in urban populations.

The trial represents the first time that international breast cancer research has included Chinese patients and opens the door to future collaborations.

Some 3700 breast cancer patients from Europe, Australia, Singapore, Japan and China will take part in the trial, led by the University of Edinburgh.

Chinese patients will be recruited from nine cancer centres across the country and will be randomly assigned one of two possible courses of treatment one to include standard post-operative care such as outpatient visits and mammogram check-ups, and another, which includes all these treatments plus radiotherapy.

Researchers will be looking for a molecular finger print of each patient's cancer to try and identify patients most likely to benefit from radiotherapy.

Professor Ian Kunkler, from the Edinburgh Cancer Research Centre at the University of Edinburgh, said: "China is experiencing a rapidly rising incidence of breast cancer, particularly in its urban populations. The results of this trial will be applicable to large numbers of people and could demonstrate differences in breast cancer that aren't found elsewhere.

"We also hope that this is just the first in many research collaborations with Chinese cancer centres. We have much to learn about these diseases and by working with on this scale we can get scientific answers more quickly."

The trial is being run in conjunction with the Breast International Group, which facilitates cooperation in large breast cancer trials. It is funded by a one million Hong Kong dollar donation by the W & E Davies Charitable Foundation.


'/>"/>

Contact: Anna Smyth
anna.smyth@ed.ac.uk
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. High alcohol consumption increases stroke risk among Chinese men
2. Heavy Drinking Boosts Stroke Risk for Chinese Men
3. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
4. Chinese takeaway in the Wadden Sea
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
7. CHRI Receives Approval for Suining Chuan DAR Authentication Trademark From Chinese Government
8. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
9. Rh-Apo2L Named as One of Chinas High-Tech Transforming Products by Chinese Government
10. What are the essential characteristics of serum PG in Chinese?
11. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Guide to ... , No matter on which side of the Atlantic devicemakers do business, ... regulations they have to follow. , In addition to the full text of the ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s ... mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... the University of Pennsylvania campus, followed by the two-day convention, which will target ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: